Terlipressin acetate

DRUG2 trials

Sponsors

River 2 Renal Corp., Novartis Pharmaceuticals

Conditions

Compensated Cirrhosis and Portal HypertensionHepatorenal Syndrome – Acute Kidney Injury

Phase 2

An Exploratory Haemodynamic Study in Patients With Compensated Cirrhosis and Portal Hypertension

CompletedNCT01640964

Novartis PharmaceuticalsCompensated Cirrhosis and Portal Hypertension

Start: 2013-04-30End: 2014-12-31Updated: 2016-03-15

A Single-blind, Phase 2, Multi-center, Randomized Study to Assess Safety, Tolerability, Efficacy and Pharmacokinetics of the Relaxin Agonist R2R01 Plus Terlipressin Versus Terlipressin Alone in Patients with Hepatorenal Syndrome – Acute Kidney Injury

CompletedCTIS2023-503504-88-00

River 2 Renal Corp.Hepatorenal Syndrome – Acute Kidney Injury

Start: 2024-05-13End: 2025-03-28Target: 18Updated: 2024-11-11

Related Papers

A phase 2 randomised controlled trial of serelaxin to lower portal pressure in cirrhosis (STOPP)

Trials2020-03-1217 citations

Serelaxin as a potential treatment for renal dysfunction in cirrhosis: Preclinical evaluation and results of a randomized phase 2 trial

PLoS Medicine2017-02-2859 citations